Advertisement

Follow-up of patients with hepatitis non-A, non-B: incidence and persistence of anti-HCV depend on route of transmission

  • K. Gmelin
  • F. Kurzen
  • B. Kallinowski
  • T. Goeser
  • J. Arnold
  • B. Kommerell
  • L. Theilmann
Part of the Archives of Virology book series (ARCHIVES SUPPL, volume 4)

Abstract

Of 32 patients with non-A, non-B hepatitis, 10 (31%) were still anti-HCV-positive 12.8 years after the acute phase of the disease. Seven of the patients (21.9%) still had elevated ALT levels, and among these, 5 out of 5 patients who had been subject to parenteral risk were anti-HCV-positive. In contrast, none of the patients who had not been subject to parenteral risks were positive.

Keywords

Acute Viral Hepatitis Parenteral Risk Parenteral Transmission Sporadic Chronic Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G (1989) Detection of antibodies to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321: 1494–1500PubMedCrossRefGoogle Scholar
  2. 2.
    Choo QL, Kuo G, Weiner AJ, Överby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359–362PubMedCrossRefGoogle Scholar
  3. 3.
    Dienstag JL (1983) Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85: 439–462PubMedGoogle Scholar
  4. 4.
    Esteban JI, Esteban R, Viladomiu L, Lopez-Talavera JC, Gonzalez A, Hernandez JM, Roget M, Vargas V, Genesca J, Buti M, Guardia J, Houghton M, Choo Q-L, Kuo G (1989) Hepatitis C virus antibodies among risk groups in Spain. Lancet ii: 294–297CrossRefGoogle Scholar
  5. 5.
    Hopf U, Möller B, Küther D, Stemerowicz R, Lobeck H, Lüdtke-Handjerry A, Walter E, Blum HE, Roggendorf M, Deinhardt F (1990) Long-term follow-up of post-transfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 10: 69–76Google Scholar
  6. 6.
    Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Kuo C, Berger K. Shuster JR, Overby LR, Bradley DW, Houghton M (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362–364PubMedCrossRefGoogle Scholar
  7. 7.
    Müller R, Willers H, Knocke KW, Sipos S, Höpken W (1979) Epidemiologie und Prognose der Hepatitis Non-A, non-B. Dtsch Med Wschr 104: 1471–1474PubMedCrossRefGoogle Scholar
  8. 8.
    Roggendorf M, Deinhardt F, Rasshofer R, Eberle J, Hopf U, Möller B, Zachoval R, Pape G, Schramm W, Rommel F (1989) Antibodies to hepatitis C virus. Lancet ii: 324–325CrossRefGoogle Scholar
  9. 9.
    Van der Poel CL, Reesink HW, Lelie PN, Leentvaar-Kuypers A, Cho Q-L, Kuo G, Houghton M (1989) Anti-hepatitis C virus antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet ii: 297–299Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • K. Gmelin
    • 1
    • 2
  • F. Kurzen
    • 1
  • B. Kallinowski
    • 1
  • T. Goeser
    • 1
  • J. Arnold
    • 1
  • B. Kommerell
    • 1
  • L. Theilmann
    • 1
  1. 1.Department of Internal MedicineUniversity of HeidelbergHeidelbergFederal Republic of Germany
  2. 2.Luitpold KlinikenBad KissingenFederal Republic of Germany

Personalised recommendations